750
Participants
Start Date
October 20, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
April 30, 2028
Intervention arm: expectant management if sFlt-1/PlGF<38
If the angiogenic factors are normal (sFlt-1/PlGF \<38), expectant management will be followed until 39 weeks, instead of delivery at ≥37 weeks of gestation as in standard care for preeclampsia without severe features.
Standard care: elective delivery at 37 weeks of gestation
In the control arm, standard care for preeclampsia without severe features will be followed: elective delivery at ≥37 weeks of gestation.
Vall d'Hebron Hospital Campus, Barcelona
Instituto de Salud Carlos III
OTHER_GOV
Hospital Universitari Vall d'Hebron Research Institute
OTHER